yniB Antibody

What is yniB protein and what is its significance in E. coli research?

The yniB protein (UniProt ID: P76208) is a predicted membrane protein found in Escherichia coli strain K12 with largely uncharacterized functions. Based on bioinformatic analyses and structural predictions, it's believed to be involved in membrane integrity and potentially plays a role in bacterial stress response mechanisms.

Methodological approach to study yniB function:

• Comparative genomics analysis against related bacterial species

• Membrane protein topology prediction using algorithms (TMHMM, Phobius)

• Gene knockout studies to assess phenotypic changes

• Co-immunoprecipitation with yniB Antibody to identify interaction partners

• Subcellular localization studies using fractionation techniques

The molecular weight of the yniB protein is predicted to be approximately 47-48 kDa, making it detectable on standard Western blots within the range that can be effectively resolved by SDS-PAGE .

What experimental applications has the yniB Antibody been validated for?

The yniB Antibody has been specifically validated for:

• Enzyme-Linked Immunosorbent Assay (ELISA)

• Western Blot (WB) applications

Methodological considerations for each application:

Western Blot validation protocol:

• Sample preparation: Use specialized membrane protein extraction protocols

• Gel percentage: 10-12% SDS-PAGE for optimal separation

• Transfer conditions: Semi-dry or wet transfer at 25V overnight for membrane proteins

• Blocking: 3-5% BSA in TBS-T (BSA often performs better than milk for membrane proteins)

• Primary antibody incubation: 1:500-1:2000 dilution, overnight at 4°C

• Detection: Enhanced chemiluminescence systems with exposure optimization

ELISA validation protocol:

• Coating: Recombinant yniB protein at 1-5 μg/ml

• Blocking: 1-3% BSA in PBS

• Antibody dilution: 1:1000-1:5000

• Detection system: HRP-conjugated secondary antibody with TMB substrate

How specific is the yniB Antibody for its target protein across bacterial species?

The yniB Antibody is a polyclonal antibody raised in rabbits using a recombinant Escherichia coli (strain K12) yniB protein immunogen . The specificity has been confirmed against its intended target through antigen affinity purification.

Methodological approaches to assess cross-reactivity:

• Sequence homology analysis:

  • Perform BLAST analysis of yniB protein sequence against related bacterial species

  • Identify potential cross-reactive epitopes through epitope prediction software

• Experimental cross-reactivity testing:

  • Western blot analysis against lysates from:

    • E. coli K12 (positive control)

    • yniB knockout E. coli (negative control)

    • Related Enterobacteriaceae species

    • Distant bacterial species

• Competitive binding assays:

  • Pre-incubate antibody with purified recombinant yniB protein

  • Apply to Western blot or ELISA

  • Observe signal reduction to confirm specificity

For maximum specificity in complex samples, researchers should consider pre-adsorption against bacterial lysates lacking yniB expression.

What are the optimal storage conditions for maintaining yniB Antibody activity?

For maximum longevity and performance of the yniB Antibody, the following storage conditions should be maintained:

Important methodological note: Upon receipt, the antibody should be immediately aliquoted to prevent repeated freeze-thaw cycles. Each freeze-thaw cycle can reduce antibody activity by approximately 10-15% .

How can researchers optimize membrane protein extraction for improved yniB detection?

Membrane proteins like yniB require specialized extraction methods to maintain structural integrity and antigenicity:

Optimized Extraction Protocol for E. coli Membrane Proteins:

• Growth and Harvest:

  • Culture E. coli to mid-logarithmic phase (OD600 0.6-0.8)

  • Harvest by centrifugation (5,000 × g, 10 min, 4°C)

  • Wash cell pellet twice with ice-cold PBS

• Spheroplast Formation:

  • Resuspend in buffer (20% sucrose, 30 mM Tris-HCl pH 8.0, 1 mM EDTA)

  • Add lysozyme (100 μg/ml) and incubate on ice for 30 min

  • Add MgCl2 to 10 mM final concentration

• Membrane Isolation:

  • Disrupt spheroplasts by sonication (6 × 10s pulses, 30s cooling intervals)

  • Remove unbroken cells and debris (15,000 × g, 20 min, 4°C)

  • Ultracentrifuge supernatant (100,000 × g, 1 h, 4°C)

  • Collect membrane pellet

• Membrane Protein Solubilization:

  • Resuspend membrane fraction in solubilization buffer:

    • 50 mM Tris-HCl (pH 7.5)

    • 150 mM NaCl

    • Detergent (choose one):

      • 1% n-Dodecyl β-D-maltoside (DDM)

      • 1% Triton X-100

      • 2% CHAPS

    • Protease inhibitor cocktail

  • Incubate with gentle rotation (2 h, 4°C)

  • Ultracentrifuge (100,000 × g, 30 min, 4°C)

  • Collect supernatant containing solubilized membrane proteins

For Western blotting applications, avoid boiling samples as this can cause membrane protein aggregation. Instead, incubate at 37°C for 10 minutes in sample buffer.

What strategies can address non-specific binding when using yniB Antibody?

Non-specific binding is a common challenge with polyclonal antibodies against bacterial proteins. Here are methodological approaches to improve specificity:

Systematic Optimization Protocol:

• Blocking optimization:

  • Test multiple blocking agents:

    • 5% BSA in TBS-T

    • 5% non-fat milk in TBS-T

    • Commercial blocking reagents (SuperBlock, etc.)

  • Extend blocking time to 2 hours at room temperature or overnight at 4°C

• Antibody dilution optimization:

  • Test serial dilutions (1:500, 1:1000, 1:2000, 1:5000)

  • Plot signal-to-noise ratio to determine optimal concentration

• Wash buffer optimization:

  • Increase Tween-20 concentration (0.05% to 0.1%)

  • Add low concentration SDS (0.01-0.05%)

  • Increase salt concentration (150 mM to 300 mM NaCl)

• Pre-adsorption strategy:

  • Incubate antibody with E. coli lysate lacking yniB expression

  • Remove complexes by centrifugation

  • Use pre-adsorbed antibody for experiments

• Cross-reactivity reduction:

  • Perform immunoaffinity purification against immobilized recombinant yniB

  • Test purified fraction against multiple bacterial species

Data from optimization experiments should be quantified using signal-to-noise ratios and documented as standard operating procedures for reproducible results.

How can researchers validate the specificity of yniB Antibody in their experimental systems?

Rigorous validation of the yniB Antibody specificity is critical for generating reliable research data:

Comprehensive Validation Strategy:

• Genetic validation:

  • Compare signal between:

    • Wild-type E. coli K12 (positive control)

    • yniB knockout strain (negative control)

    • yniB overexpression strain (enhanced signal)

• Peptide competition assay:

  • Pre-incubate antibody with excess recombinant yniB protein

  • Perform parallel Western blots with competed and non-competed antibody

  • Specific signal should be significantly reduced or abolished

• Orthogonal detection methods:

  • Generate epitope-tagged yniB constructs (e.g., His-tag, FLAG-tag)

  • Perform dual detection with anti-tag antibody and yniB Antibody

  • Signals should co-localize on Western blots

• Mass spectrometry validation:

  • Perform immunoprecipitation with yniB Antibody

  • Analyze pulled-down proteins by mass spectrometry

  • Confirm presence of yniB protein and identify potential cross-reactants

• Signal depletion assay:

  • Perform sequential immunoprecipitations

  • Analyze depletion of target protein from the lysate

  • Signal should diminish with successive rounds

These validation approaches should be documented in publications to strengthen the reliability of experimental findings using the yniB Antibody.

What are the possible experimental pitfalls when using yniB Antibody for co-immunoprecipitation studies?

Co-immunoprecipitation (Co-IP) with membrane proteins like yniB presents unique challenges:

Common Pitfalls and Solutions:

• Insufficient protein solubilization:

  • Problem: Membrane proteins like yniB may not fully solubilize in standard IP buffers

  • Solution: Optimize detergent type and concentration through systematic testing:

    • Test panel: DDM (0.5-1%), Digitonin (0.5-1%), CHAPS (1-2%)

    • Measure solubilization efficiency by Western blot of soluble vs. insoluble fractions

• Disruption of protein-protein interactions:

  • Problem: Harsh detergents can disrupt native protein complexes

  • Solution: Use milder detergents and crosslinking approach:

    • Crosslink cells with DSP (1 mM, 30 min) before lysis

    • Use reversible crosslinkers that can be cleaved before SDS-PAGE

• Antibody binding interference:

  • Problem: Detergents may interfere with antibody-epitope recognition

  • Solution: Test antibody binding efficiency in the presence of various detergents

    • Perform dot blots of recombinant protein in different detergent buffers

    • Select conditions that maintain binding while solubilizing target

• High background from non-specific binding:

  • Problem: Bacterial lysates can cause high background

  • Solution: Implement stringent washing and pre-clearing:

    • Pre-clear lysate with Protein A/G beads (1 hour, 4°C)

    • Include appropriate detergent and salt in wash buffers

    • Consider tandem purification with tagged constructs

• False positive interactions:

  • Problem: Common contaminants in membrane Co-IP

  • Solution: Use stringent controls:

    • IgG control from same species as yniB Antibody

    • Perform Co-IP from yniB knockout strain

    • Implement SILAC or other quantitative MS approaches to filter contaminants

These methodological considerations should be systematically tested and optimized for each experimental system.

How can researchers troubleshoot inconsistent Western blot results with yniB Antibody?

When facing variable or inconsistent results, a systematic troubleshooting approach is essential:

Structured Troubleshooting Protocol:

• No signal detected:

  • Verify protein expression: Confirm yniB expression levels in your sample

  • Extraction efficiency: Ensure membrane proteins are properly solubilized

  • Antibody activity: Test functionality with recombinant protein control

  • Transfer efficiency: Verify with reversible protein stain (Ponceau S)

  • Detection sensitivity: Try more sensitive ECL substrate or longer exposure

• Weak signal:

  • Antibody concentration: Reduce dilution (1:500 instead of 1:2000)

  • Incubation time: Extend to overnight at 4°C

  • Protein loading: Increase amount of total protein loaded

  • Detection system: Switch to more sensitive chemiluminescence reagent

  • Membrane type: Try PVDF instead of nitrocellulose for higher protein binding

• Multiple bands:

  • Protein degradation: Add fresh protease inhibitors during extraction

  • Sample heating: Test non-heated vs. heated (37°C vs. 95°C) samples

  • Reducing conditions: Compare reducing vs. non-reducing conditions

  • Antibody specificity: Perform peptide competition assay

  • Post-translational modifications: Analyze with phosphatase or glycosidase treatment

• High background:

  • Blocking optimization: Test alternative blocking agents (BSA vs. milk)

  • Washing stringency: Increase wash duration and number of washes

  • Antibody dilution: Increase dilution (1:5000 instead of 1:1000)

  • Secondary antibody: Reduce concentration or try alternative supplier

  • Membrane cleanliness: Ensure no fingerprints or contaminants on membrane

For each troubleshooting parameter, document changes systematically to identify the critical variables affecting your experimental system.

What methods can quantify the binding affinity of yniB Antibody to its target?

Quantitative analysis of antibody-antigen interactions provides valuable insights into antibody performance characteristics:

Surface Plasmon Resonance (SPR) Protocol:

• Immobilize purified recombinant yniB on CM5 sensor chip

• Prepare yniB Antibody dilution series (0.1-100 nM)

• Inject antibody at multiple concentrations

• Measure association (ka) and dissociation (kd) rates

• Calculate equilibrium dissociation constant (KD = kd/ka)

Quantitative ELISA Protocol:

• Coat microplate wells with recombinant yniB (0.1-10 μg/ml)

• Block with 3% BSA in PBS

• Add serial dilutions of yniB Antibody

• Detect with HRP-conjugated secondary antibody

• Generate binding curve and calculate EC50

Bio-Layer Interferometry (BLI) Protocol:

• Load biotinylated yniB onto streptavidin biosensors

• Prepare antibody dilution series (1-100 nM)

• Measure real-time binding kinetics

• Determine association and dissociation rates

• Calculate KD value using global fitting

These quantitative approaches are valuable for:

• Comparing different antibody lots

• Assessing effects of storage conditions on activity

• Predicting performance in various applications

• Determining optimal working concentrations

How can researchers develop quantitative Western blot protocols for yniB protein?

Quantitative Western blotting requires careful optimization and standardization:

Quantitative Western Blot Protocol:

• Sample preparation standardization:

  • Extract membrane proteins using consistent protocol

  • Quantify total protein using BCA or Bradford assay

  • Prepare serial dilutions of samples (100%, 50%, 25%, 12.5%)

• Loading control selection:

  • Select appropriate membrane protein loading controls:

    • ATP synthase subunits

    • Specific outer membrane proteins

    • Consistently expressed transporters

  • Verify linear response range for loading control

• Gel and transfer parameters:

  • Use precast gels for consistency

  • Maintain consistent transfer conditions:

    • Same transfer buffer composition

    • Fixed voltage and transfer time

    • Temperature monitoring during transfer

• Antibody detection optimization:

  • Determine linear range of antibody detection:

    • Test serial dilutions of positive control

    • Plot band intensity vs. concentration

    • Identify linear detection range

  • Use optimized antibody concentration within linear range

• Signal detection and analysis:

  • Use digital imaging system with wide dynamic range

  • Avoid signal saturation

  • Analyze using software with background subtraction

  • Normalize target protein to loading control

  • Include standard curve on each blot

Representative data table for optimization:

The linearity of the normalized ratio across dilutions confirms quantitative reliability of the method.

What strategies can enhance detection sensitivity for low-abundance yniB protein?

When working with low-abundance membrane proteins like yniB, specialized methods can significantly improve detection:

Enhanced Sensitivity Protocol:

• Sample enrichment techniques:

  • Membrane fractionation to concentrate target

  • Immunoprecipitation before Western blotting

  • Ultracentrifugation to pellet membrane fractions

• Signal amplification methods:

  • Switch to high-sensitivity ECL substrate (femtogram detection)

  • Implement tyramide signal amplification (TSA):

    • Use HRP-conjugated secondary antibody

    • Add biotinylated tyramide and hydrogen peroxide

    • Detect with streptavidin-HRP

    • Provides 10-100× signal enhancement

• Detection system optimization:

  • Use PVDF membrane (higher protein binding capacity)

  • Reduce membrane pore size (0.2 μm instead of 0.45 μm)

  • Optimize transfer conditions for membrane proteins:

    • Add 0.1% SDS to transfer buffer

    • Transfer at lower voltage for longer time

    • Use specialized transfer systems for membrane proteins

• Alternative detection methods:

  • Consider fluorescent Western blotting:

    • Lower background than chemiluminescence

    • Wider dynamic range for quantification

    • Multiple target detection capability

  • Try capillary-based automated Western systems:

    • Higher sensitivity than traditional methods

    • Better reproducibility and quantification

• Blocking and antibody incubation optimization:

  • Test alternative blocking agents:

    • Commercial blockers specifically for membrane proteins

    • Specialized blocking solutions for low-abundance targets

  • Extend primary antibody incubation (48h at 4°C)

  • Use antibody incubation enhancers

These approaches can improve detection limits by 5-20 fold compared to standard Western blotting protocols.

How can researchers apply the yniB Antibody in novel research applications beyond validated methods?

While the yniB Antibody is validated for ELISA and Western blotting , researchers can adapt it for additional applications with proper optimization:

Immunofluorescence Microscopy Adaptation:

• Fix E. coli cells with 4% paraformaldehyde (10 min)

• Permeabilize with 0.1% Triton X-100 (5 min)

• Block with 3% BSA in PBS (1 hour)

• Incubate with yniB Antibody (1:100 dilution, overnight at 4°C)

• Detect with fluorophore-conjugated secondary antibody

• Include membrane dye (FM4-64) for co-localization analysis

Flow Cytometry Protocol:

• Fix bacterial cells with 2% paraformaldehyde

• Permeabilize with 0.1% Triton X-100

• Block with 3% BSA in PBS

• Incubate with yniB Antibody (1:100 dilution)

• Detect with fluorophore-conjugated secondary antibody

• Analyze by flow cytometry with appropriate controls

Chromatin Immunoprecipitation (ChIP) Adaptation:

• Crosslink bacteria with 1% formaldehyde

• Lyse cells and sonicate to shear DNA

• Immunoprecipitate with yniB Antibody

• Reverse crosslinks and purify DNA

• Analyze by qPCR or sequencing to identify DNA binding sites

• Useful for studying potential DNA-binding functions of yniB

Super-Resolution Microscopy:

• Prepare bacterial samples as for immunofluorescence

• Use secondary antibodies compatible with STORM/PALM

• Implement dual-color imaging with membrane markers

• Analyze nanoscale distribution of yniB protein

• Quantify clustering and membrane domain association

For each novel application, include appropriate positive and negative controls to validate the specificity of the observed signals in these extended applications.

How can researchers use yniB Antibody to study bacterial stress responses?

Membrane proteins like yniB often play roles in stress response pathways. Here's a methodological approach to investigate this function:

Stress Response Analysis Protocol:

• Stress condition panel testing:

  • Expose E. coli cultures to various stressors:

    • Osmotic stress (0.5 M NaCl)

    • Oxidative stress (1 mM H₂O₂)

    • pH stress (pH 5.0 and pH 9.0)

    • Membrane stress (sub-MIC antibiotics)

    • Heat shock (42°C)

• Time-course analysis:

  • Collect samples at multiple timepoints (0, 15, 30, 60, 120 min)

  • Extract membrane proteins using optimized protocol

  • Perform quantitative Western blotting with yniB Antibody

  • Normalize to stable membrane protein control

• Correlation with stress markers:

  • Parallel analysis of known stress response proteins:

    • σE-regulated proteins

    • Heat shock proteins

    • SOS response proteins

  • Identify potential co-regulation patterns

• Functional assessment:

  • Compare stress sensitivity between:

    • Wild-type E. coli

    • yniB knockout mutant

    • yniB overexpression strain

  • Measure survival rates under stress conditions

  • Assess membrane integrity using fluorescent dyes

• Protein interaction networks:

  • Perform stress-dependent Co-IP with yniB Antibody

  • Identify stress-specific interaction partners

  • Map potential signaling pathways

This systematic approach can reveal the functional role of yniB in bacterial stress response mechanisms and provide insights into membrane protein dynamics under adverse conditions.

What methodological approaches can identify protein-protein interactions involving yniB?

Understanding the protein interaction network of yniB can provide valuable insights into its function:

Comprehensive Interaction Mapping Strategy:

• Antibody-based co-immunoprecipitation:

  • Optimize membrane protein extraction with mild detergents

  • Perform Co-IP with yniB Antibody under different conditions

  • Identify interacting partners by mass spectrometry

  • Validate top candidates with reverse Co-IP

• Proximity labeling approaches:

  • Generate yniB-BioID or yniB-APEX2 fusion proteins

  • Express in E. coli and activate labeling

  • Purify biotinylated proteins with streptavidin

  • Identify proximal proteins by mass spectrometry

  • Compare against appropriate controls

• Cross-linking mass spectrometry:

  • Treat bacterial cells with membrane-permeable crosslinkers

  • Purify yniB and crosslinked complexes

  • Digest and analyze by LC-MS/MS

  • Identify crosslinked peptides using specialized software

  • Map interaction surfaces at amino acid resolution

• Bacterial two-hybrid screening:

  • Generate yniB bait constructs

  • Screen against E. coli genomic library

  • Identify positive interactions through reporter activation

  • Validate with alternative interaction assays

• Split-GFP complementation:

  • Fuse yniB to GFP fragment 1-10

  • Fuse candidate interactors to GFP fragment 11

  • Co-express in E. coli

  • Visualize interactions through GFP fluorescence

  • Quantify interaction strength by fluorescence intensity

For each approach, include appropriate controls (unrelated membrane proteins, empty vectors) and confirm biological relevance through functional assays.

How can researchers interpret contradictory results when studying yniB localization?

Membrane protein localization studies can sometimes yield contradictory results due to technical and biological variables:

Systematic Resolution Strategy:

• Method comparison analysis:

  • Apply multiple independent localization techniques:

    • Immunofluorescence with yniB Antibody

    • Fluorescent protein fusions (yniB-GFP)

    • Subcellular fractionation with Western blotting

    • Electron microscopy with immunogold labeling

  • Document conditions for each technique precisely

  • Compare results systematically

• Technical variable assessment:

  • Test fixation methods:

    • Paraformaldehyde (2-4%)

    • Glutaraldehyde (0.1-0.5%)

    • Methanol (-20°C)

  • Compare permeabilization approaches:

    • Triton X-100 (0.1-0.5%)

    • Digitonin (25-100 μg/ml)

    • Lysozyme treatment

  • Evaluate antibody accessibility issues

• Biological condition variables:

  • Growth phase effects:

    • Log phase

    • Stationary phase

    • Stress conditions

  • Protein expression level impact:

    • Native expression

    • Overexpression effects

    • Induction conditions

• Epitope availability analysis:

  • Generate epitope-tagged constructs at different positions

  • Compare localization patterns

  • Assess potential masking effects

• High-resolution imaging:

  • Use super-resolution microscopy (STORM, PALM)

  • Apply deconvolution algorithms

  • Perform quantitative colocalization analysis

  • Consider 3D reconstruction approaches

Representative data comparing localization findings:

What experimental design is optimal for studying yniB expression under different physiological conditions?

To comprehensively investigate yniB expression regulation:

Multi-level Expression Analysis Protocol:

• Transcriptional regulation:

  • Construct yniB promoter-reporter fusions:

    • Pynb-lacZ for β-galactosidase assays

    • Pynb-gfp for fluorescence measurements

  • Test expression across conditions:

    • Growth phases (lag, log, stationary)

    • Nutrient limitations

    • Environmental stressors

    • Temperature variations

  • Perform qRT-PCR for mRNA quantification

  • Identify potential transcription factor binding sites

• Translational regulation:

  • Analyze ribosome profiling data

  • Construct translational fusions

  • Assess regulation by small RNAs

  • Investigate mRNA stability

  • Examine potential RNA thermosensors

• Protein-level regulation:

  • Quantitative Western blotting with yniB Antibody

  • Measure protein half-life using translation inhibition

  • Investigate post-translational modifications:

    • Phosphorylation

    • Glycosylation

    • Proteolytic processing

  • Determine turnover rate with pulse-chase experiments

• Integrated systems analysis:

  • Correlate transcriptomic and proteomic data

  • Identify discrepancies indicating post-transcriptional control

  • Map regulation networks using bioinformatic approaches

• Genetic validation:

  • Generate targeted mutations in regulatory elements

  • Assess impact on expression patterns

  • Identify key regulators through deletion studies

This systematic approach allows researchers to distinguish between transcriptional, translational, and post-translational regulation of yniB expression across different physiological conditions.

How can researchers utilize the yniB Antibody in comparative studies across bacterial species?

Cross-species analyses can provide evolutionary insights into yniB function:

Comparative Analysis Protocol:

• Bioinformatic phylogenetic analysis:

  • Identify yniB homologs across bacterial species

  • Construct phylogenetic tree

  • Map conserved domains and motifs

  • Predict epitope conservation

• Cross-reactivity experimental validation:

  • Test yniB Antibody against lysates from:

    • Closely related Enterobacteriaceae

    • Divergent Gram-negative bacteria

    • Gram-positive bacteria as negative controls

  • Document signal pattern and intensity

  • Confirm specificity with appropriate controls

• Expression pattern comparison:

  • Culture diverse bacterial species under identical conditions

  • Extract membrane proteins using optimized protocol

  • Perform quantitative Western blotting

  • Compare expression levels across species

  • Correlate with environmental adaptations

• Functional conservation assessment:

  • Compare yniB knockout phenotypes across species

  • Test complementation with heterologous expression

  • Evaluate stress response roles in different bacteria

  • Map structure-function relationships

• Co-evolutionary analysis:

  • Identify consistently co-occurring genes across species

  • Map potential interacting partners

  • Test interaction conservation experimentally

  • Relate to niche-specific adaptations